| Name | Title | Contact Details |
|---|
Mediatrope LLC is a San Francisco, CA-based company in the Software and Internet sector.
Innovative organizations across industries use Micro-Internships to identify, engage, assess and hire high-potential college students and recent graduates.
Each year, Breakthrough hosts an event called The Mercury Group. This annual gathering of shipper clients invites attendees to...
Industry leading suite of tools to isolate consumer accounts that file lawsuits against collection agencies, creditors and debt collectors and other businesses.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.